Breaking news: Cladribine will be made more accessible for people with MS

In this video Rachel interviews Professor Gavin Giovannoni who is a Consultant Neurologist. The interview was filmed by Jason

Video transcript

Expert: Prof. Gavin Giovannoni, Consultant Neurologist, Barts, London

MS Reporter: Rachel

More videos about Treatment category

dominics says:

Why do you think, at 0.55, in does Professor Giovanni find it remarkable that Cladribine has been selected? Do you think it is that he is happy, approving and surprised or does he feel, perhaps, that there are other more worthy candidates?

A key observation is at 1:20 when prof Giovanni obsevers how few people in the UK with MS who should be on treatment, aren’t.

I wonder why that is? What keeps people from being treated? Their medics or them?

Leave a Reply

Have you found this video useful? Please let us know by filling in this short survey.
Join the Shift.ms communityclose